|
Match
|
Document |
Document Title |
|
|
7618649 |
Extended release oral dosage composition
A bilayer solid composition comprising (a) an immediate release first layer comprising an anti-allergic effective amount of desloratadine and at least one pharmaceutically acceptable excipient and...
|
|
|
7616111 |
System to monitor the ingestion of medicines
A system for monitoring ingestion of medicine ( 21 ) comprises forming a digestible radio frequency identification (RFID) tag ( 10 ). The RFID tag is attached to the medicine. The RFID tag and...
|
|
|
7595063 |
Compressed tablet formulation
This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the...
|
|
|
7588779 |
Pharmaceutical formulation containing a biguanide and an angiotensin antagonist
A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a angiotensin antagonist is herein...
|
|
|
7585520 |
Compositions containing both sedative and non-sedative antihistamines and sleep aids
Compositions containing both a sedative compound and a non-sedative antihistamine are provided. More particularly, compositions for administration at bedtime containing a sedating antihistamine or...
|
|
|
7579020 |
Controlled release arginine α-ketoglutarate
An oral formulation of arginine α-ketoglutarate is disclosed which formulation is comprised of arginine α-ketoglutarate and one or more excipient materials. A wide range of different controlled...
|
|
|
7575760 |
Chewable tablet containing lysine
A tablet with enhanced compliance by humans, in particular children and/or juveniles, comprising:
(a) a vitamin; (b) lysine or a pharmaceutically acceptable salt thereof; (c) a sweetener;...
|
|
|
7572463 |
Oral dosage forms
A controlled-release oral dosage formulation of a salt-forming active ingredient, wherein the active ingredient is present as at least two different salts in a solid aggregation state, wherein the...
|
|
|
7566462 |
Stable tablet formulation
The present invention is directed to a stable solid formulations of tetrahydrobiopterin, processes for producing them, and treatment methods using such formulations.
|
|
|
7556799 |
Ion binding polymers and uses thereof
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and...
|
|
|
7553499 |
Sustained release tablet containing indapamide
The present invention relates to a sustained release tablet containing indapamide and the process of manufacturing sustained release tablet containing indapamide. The tablet contains indapamide in...
|
|
|
7550158 |
Controlled release by extrusion of solid amorphous dispersions of drugs
Controlled release dosage forms for low solubility drugs are disclosed wherein an amorphous solid dispersion of the drug is coated with a non-dissolving and non-eroding coating that controls the...
|
|
|
7544327 |
Biosensor and method for bone mineral density measurement
This invention is related a biosensor for bone mineral density measurement, comprising a stimulating source; a transducer having antibodies against TRAP 5a, TRAP 5b or total TRAP (i.e. TRAP 5a+TRAP...
|
|
|
7537784 |
Modified release tablet of bupropion hydrochloride
A modified-release tablet of bupropion hydrochloride comprising (i) a core comprising an effective amount of bupropion hydrochloride, a binder, a lubricant; and (ii) a control releasing coat...
|
|
|
7527808 |
Amorphous cefditoren pivoxil composition and process for producing the same
An objective of the present invention is to provide an amorphous cefditoren pivoxil composition possessing excellent stability and dissolvability and to provide a production process of the...
|
|
|
7527807 |
Compositions and methods for increasing the oral absorption of antimicrobials
The present invention provides compositions and methods for increasing absorption of antibacterial agents, particularly third generation cephalosporin antibacterial agents, in oral dosage solid...
|
|
|
7524515 |
Pharmaceutical safety dosage forms
Pharmaceutical safety dosage forms are provided which include a pharmaceutical and an antagonist to the pharmaceutical. The safety dosage forms are such that the antagonist has no significant...
|
|
|
7521072 |
Dietary fiber delivery system
A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability.
|
|
|
7514100 |
Controlled release hydrocodone formulations
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
|
|
|
7510728 |
Solid preparations
In a solid pharmaceutical preparation containing 1) a basic medicinal component having an unpleasant taste; 2) a saccharide; 3) a polyanionic polymer; 4) a corrigent; and 5) carboxymethylcellulose,...
|
|
|
7498044 |
Dosage form and method for producing the same
The invention relates to a process for producing a coated drug form or a drug form in the form of an active ingredient matrix, by processing a copolymer, an active pharmaceutical ingredient, a core...
|
|
|
7494980 |
Antimicrobial peptide and methods of use thereof
A method of preventing biofilm formation in an environment including the steps of administering to the environment an effective amount of a peptide having the amino acid sequence NH 2...
|
|
|
7494668 |
Fast water-dispersible domperidone tablets
The present invention relates to fast water-dispersible tablets containing domperidone for oral administration. The formulations comprise domperidone or pharmaceutically acceptable salts thereof,...
|
|
|
7488498 |
Antidiabetic preparation for oral administration
There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a...
|
|
|
7485319 |
Doxycycline metal complex in a solid dosage form
The present invention is a solid dosage form of a doxycycline metal complex. The present invention also includes a process for making a doxycycline metal complex in a solid dosage form. The process...
|
|
|
7482022 |
Palatable chewable tablet
A palatable chewable tablet is described herein for oral administration of cetirizine dihydrochloride. The formulation is made more palatable by incorporating a combination of a grape flavoring...
|
|
|
7476403 |
Oral extended-release composition
The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient...
|
|
|
7470435 |
Extended release venlafaxine formulation
A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
|
|
|
7465465 |
Pharmaceutical formulation comprising lanthanum compounds
This invention relates to a chewable lanthanum formulation comprising a pharmaceutically effective amount of a lanthanum compound; and at least one chewable pharmaceutically acceptable excipient....
|
|
|
7465462 |
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a...
|
|
|
7459173 |
Medicament for prevention and treatment of bone fracture and osteoporosis
A pharmaceutical composition which can be used to prevent and treat bone fracture and osteoporosis. The composition is composed of Semen lactucae sativae 0.1-1, Lignum aquilariae resinatum ...
|
|
|
7455857 |
Energy generating composition
The present invention is drawn to an ephedra- and artificial stimulant-free energy promoting composition, comprising effective amounts of a magnesium amino acid chelate, a B vitamin, a pyruvate...
|
|
|
7445796 |
Pharmaceutically active particles of a monomodal particle size distribution and method
A method of obtaining improved reproducibility of dissolution profiles of dosage forms containing pharmaceutically active particles includes steps of screening raw pharmaceutically active particles...
|
|
|
7442387 |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
The present invention pertains to a sized product, which contains a drug, polyethylene oxide with a molecular weight of 2,000,000 or higher, and a specific size controlling agent for polyethylene...
|
|
|
7438930 |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration...
|
|
|
7438927 |
Methods of treatment using a gastric retained gabapentin dosage
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
|
|
|
7431944 |
Delivery of multiple doses of medications
Dosage forms for oral administration of a methylphenidate drug are provided. The dosage forms provide a substantially immediate dose of methylphenidate upon ingestion, followed by one or more...
|
|
|
7431943 |
Controlled release and taste masking oral pharmaceutical compositions
Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic,...
|
|
|
7431942 |
Orally disintegrable tablets
An orally disintegrable tablet of the present invention, which comprises (i) fine granules having an average particle diameter of 400 μm or less, which fine granules comprise a composition coated...
|
|
|
7422758 |
Sustained release vitamin composition
A therapeutic formulation in the form of a beadlet, suitable for oral administration and adapted to provide immediate and sustained release of therapeutic material. Each beadlet comprises an...
|
|
|
7422757 |
Tabletting process
The invention refers to a process for the preparation of a self-dispersing or self-emulsifying tablet, wherein a heated granulation mixture containing an active lipophilic substance and a...
|
|
|
7419686 |
Opioid agonist/antagonist combinations
The invention is directed in part to oral dosage forms comprising a combination of an orally analgesically effective amount of an opioid agonist and an orally active opioid antagonist, the opioid...
|
|
|
7419685 |
Process for producing solid dosage forms
Solid dosage forms containing at least one polymer binder, at least one active ingredient and, where appropriate, conventional additives, wherein a physiologically tolerated, water-swellable graft...
|
|
|
7419684 |
System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
A system and method for manufacturing oral osmotic drug delivery devices including the use of a mathematical model in deriving relationships between parameters used in manufacturing the devices for...
|
|
|
7417022 |
Compounds and compositions for delivering active agents
Modified amino acid compounds useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
7416738 |
Modified release dosage form
A modified release dosage form comprising at least one active ingredient and at least two cores surrounded by a shell is provided. The shell comprises at least one opening and provides for modified...
|
|
|
7413751 |
Methods of treatment using a gastric retained losartan dosage
A method of treatment for hypertension and other disease states is described, which comprises the delivery of losartan in a gastric retained dosage form.
|
|
|
7404968 |
Metering and packaging of controlled release medication
Controlled quantities of powdered medication are formed in controlled release packages using electrostating metering. Also provided are combination medication therapy delivery packages comprising...
|
|
|
7402321 |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
|
|
|
7399488 |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, a drug...
|